Chat with us, powered by LiveChatHorizon 2020: Innovative Medicines Initiative - H2020-JTI-IMI2-2019-17-two-stage - FASI
FASI - Funding Aid Strategies Investments

Horizon 2020: Innovative Medicines Initiative - H2020-JTI-IMI2-2019-17-two-stage

23 gennaio 2019
STANZIAMENTO
€ 83.894.139
SCADENZA
25/04/2019

Innovative Medicines Initiative: 17th Call for proposals.

The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry. IMI facilitates open collaboration in research to advance the development of, and accelerate patient access to, personalised medicines for the health and wellbeing of all, especially in areas of unmet medical need.

The goal of IMI, particularly in its second phase (IMI2, 2014-2020) is to develop next generation vaccines, medicines and treatments, such as new antibiotics.

Topics

  • Opt
;